Alan J Russell is Chief Scientific Officer of Edgewise Therapeutics, Inc.. Currently has a direct ownership of 7,238 shares of EWTX, which is worth approximately $140,634. The most recent transaction as insider was on Oct 01, 2021, when has been sold 274 shares (Common Stock) at a price of $18.0 per share, resulting in proceeds of $4,932. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 7.24K
100.72% 3M change
95.89% 12M change
Total Value Held $140,634

Alan J Russell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 01 2021
SELL
Open market or private sale
$4,932 $18.0 p/Share
274 Reduced 0.15%
178,826 Common Stock
Sep 29 2021
SELL
Open market or private sale
$203,125 $17.15 p/Share
11,844 Reduced 6.2%
179,100 Common Stock
Sep 28 2021
SELL
Open market or private sale
$252,753 $17.3 p/Share
14,610 Reduced 7.11%
190,944 Common Stock
Sep 27 2021
SELL
Open market or private sale
$211,669 $18.23 p/Share
11,611 Reduced 5.35%
205,554 Common Stock
Sep 24 2021
SELL
Open market or private sale
$365,016 $18.16 p/Share
20,100 Reduced 8.47%
217,165 Common Stock
Sep 23 2021
SELL
Open market or private sale
$506,645 $18.88 p/Share
26,835 Reduced 10.16%
237,265 Common Stock
AJR

Alan J Russell

Chief Scientific Officer
Boulder, CO

Track Institutional and Insider Activities on EWTX

Follow Edgewise Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EWTX shares.

Notify only if

Insider Trading

Get notified when an Edgewise Therapeutics, Inc. insider buys or sells EWTX shares.

Notify only if

News

Receive news related to Edgewise Therapeutics, Inc.

Track Activities on EWTX